MDL Mass Tort & Class Action Monitor
Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
SEARCH THE ARCHIVES
Issue #8, July 2017
Lawsuits filed by nine New York Counties alleging that drug makers have, for years, misrepresented the dangers of prescription opioids will be transferred to a single state court justice in Suffolk County, according to an order issued July 18.
Issue #7, June 2017
The Judicial Panel on Multidistrict Litigation has granted plaintiffs’ request to create a consolidated docket for federal lawsuits alleging injury caused by the synthetic hernia repair product Physiomesh.
Plaintiffs alleging injuries caused by several popular heartburn drugs have renewed their effort to transfer all similar cases to a single federal judge, arguing that the number of claims has ballooned since a federal judicial panel refused to create a centralized docket for the litigation earlier this year.
Issue #6, May 2017
A Georgia woman alleges in a new federal lawsuit that defective, leaking Mentor saline breast implants caused her to develop bio-toxin disease and mold infection.
In an action brought against a railroad under the Federal Employers’ Liability Act, the U.S. Supreme Court held that due process bars a state court from exercising general personal jurisdiction over a defendant that is not “at home” in the forum state.
A Florida woman who claims she developed liver tumors after prolonged use of the Seasonale and Seasonique has sued the manufacturer of the oral contraceptives, claiming the company failed to warn of a significant risk of tumors associated with the drugs.
Issue #5, April 2017
Plaintiffs suing companies involved in the production, supply and marketing of EpiPens have filed a motion with the Judicial Panel on Multidistrict Litigation to coordinate all federal actions alleging that the defendants conspired to eliminate competition and raise the cost of the devices.
In their second attempt in two years, plaintiffs have persuaded the Judicial Panel on Multidistrict Litigation to create a centralized MDL docket for claims alleging intracranial hypertension caused by Bayer’s Mirena IUD contraceptive system.
Users of the type 2 diabetes drug Farxiga who have sued Bristol-Myers Squibb Co. and AstraZeneca in federal court over kidney-related injuries will have their cases initially heard by a single judge in New York, according to an order issued by the U.S. Judicial Panel on Multidistrict Litigation.
Claims alleging injury caused by the Sorin 3T Heater-Cooler device will not be litigated in a formally consolidated docket after the Judicial Panel on Multidistrict Litigation ruled April 5 that the cases are already being informally, and successfully, coordinated in South Carolina and elsewhere.